Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Hospitalization of children after prenatal exposure to opioid maintenance therapy during pregnancy: a national registry study from the Czech Republic

S. Skurtveit, B. Nechanská, M. Handal, M. Mahic, V. Mravčík, R. Gabrhelík,

. 2019 ; 114 (7) : 1225-1235. [pub] 20190312

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20025781

Grantová podpora
16-28157A Ministry of Health of the Czech Republic - International
NV16-28157A MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek

E-zdroje Online Plný text

NLK CINAHL Plus with Full Text (EBSCOhost) od 2003-03-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 1993-01-01 do Před 1 rokem

BACKGROUND AND AIMS: Our understanding of the long-term safety of prenatal exposure to opioid maintenance treatment (OMT) is insufficient. We compared childhood morbidity (0-3 years) between OMT-exposed and relevant comparison groups. DESIGN: Nation-wide, registry-based cohort study. Registries on reproductive health, addiction treatment, hospitalization and death were linked using identification numbers. SETTING: The Czech Republic (2000-14). PARTICIPANTS: Children with different prenatal exposure: (i) mother in OMT during pregnancy (OMT; n = 218), (ii) mother discontinued OMT before pregnancy (OMT-D; n = 55), (iii) mother with opioid use disorder, but not in OMT during pregnancy (OUD; n = 85) and (iv) mother in the general population (GP) (n = 1 238 452) MEASUREMENTS: Episodes of hospitalization were observed as outcomes. Information on in-patient contacts, length of stay and diagnoses (International Classification of Diseases version 10) were assessed. Binary logistic regressions were conducted to estimate the associations between OMT exposure and the outcomes, crude and adjusted for the socio-economic status and smoking. FINDINGS: No significant differences were found in the overall proportion of hospitalization among OMT-exposed children, children of OMT-D and children of women with OUD [54.1%, 95% confidence interval (CI) = 47.3-60.1%; 47.3%, 95% CI = 33.9-61.1%; 51.8%, 95% CI = 40.7%-62.6%], while the proportion was significantly lower (35.8%, 95% CI = 35.7-35.8%) in the GP. There were no significant differences in risk of specific diagnoses between OMT-exposed children, children of OMT-D and children of women with OUD. In the adjusted analyses, differences between OMT-exposed and children in the GP were still present for infections and parasitic diseases (OR = 2.0, 95% CI = 1.4-2.7), diseases of the digestive system (OR = 1.7, 95% CI = 1.2-2.6) and diseases of the skin and subcutaneous tissue (OR = 1.9, 95% CI = 1.2-3.2). CONCLUSION: This study did not find clear evidence for an increase in risk of morbidity during the first 3 years of life in children with prenatal opioid maintenance treatment exposure compared with children of women who discontinued such treatment before pregnancy or suffered from opioid use disorder without this treatment. Compared the general population, there appears to be an increased risk of hospitalizations for infectious, gastrointestinal and skin diseases.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025781
003      
CZ-PrNML
005      
20201222154103.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/add.14576 $2 doi
035    __
$a (PubMed)30725515
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Skurtveit, Svetlana $u Norwegian institute of Public Health, Oslo, Norway. Norwegian Centre for Addiction Research at the University of Oslo, Norway.
245    10
$a Hospitalization of children after prenatal exposure to opioid maintenance therapy during pregnancy: a national registry study from the Czech Republic / $c S. Skurtveit, B. Nechanská, M. Handal, M. Mahic, V. Mravčík, R. Gabrhelík,
520    9_
$a BACKGROUND AND AIMS: Our understanding of the long-term safety of prenatal exposure to opioid maintenance treatment (OMT) is insufficient. We compared childhood morbidity (0-3 years) between OMT-exposed and relevant comparison groups. DESIGN: Nation-wide, registry-based cohort study. Registries on reproductive health, addiction treatment, hospitalization and death were linked using identification numbers. SETTING: The Czech Republic (2000-14). PARTICIPANTS: Children with different prenatal exposure: (i) mother in OMT during pregnancy (OMT; n = 218), (ii) mother discontinued OMT before pregnancy (OMT-D; n = 55), (iii) mother with opioid use disorder, but not in OMT during pregnancy (OUD; n = 85) and (iv) mother in the general population (GP) (n = 1 238 452) MEASUREMENTS: Episodes of hospitalization were observed as outcomes. Information on in-patient contacts, length of stay and diagnoses (International Classification of Diseases version 10) were assessed. Binary logistic regressions were conducted to estimate the associations between OMT exposure and the outcomes, crude and adjusted for the socio-economic status and smoking. FINDINGS: No significant differences were found in the overall proportion of hospitalization among OMT-exposed children, children of OMT-D and children of women with OUD [54.1%, 95% confidence interval (CI) = 47.3-60.1%; 47.3%, 95% CI = 33.9-61.1%; 51.8%, 95% CI = 40.7%-62.6%], while the proportion was significantly lower (35.8%, 95% CI = 35.7-35.8%) in the GP. There were no significant differences in risk of specific diagnoses between OMT-exposed children, children of OMT-D and children of women with OUD. In the adjusted analyses, differences between OMT-exposed and children in the GP were still present for infections and parasitic diseases (OR = 2.0, 95% CI = 1.4-2.7), diseases of the digestive system (OR = 1.7, 95% CI = 1.2-2.6) and diseases of the skin and subcutaneous tissue (OR = 1.9, 95% CI = 1.2-3.2). CONCLUSION: This study did not find clear evidence for an increase in risk of morbidity during the first 3 years of life in children with prenatal opioid maintenance treatment exposure compared with children of women who discontinued such treatment before pregnancy or suffered from opioid use disorder without this treatment. Compared the general population, there appears to be an increased risk of hospitalizations for infectious, gastrointestinal and skin diseases.
650    _2
$a dospělí $7 D000328
650    _2
$a opioidní analgetika $x terapeutické užití $7 D000701
650    _2
$a buprenorfin $x terapeutické užití $7 D002047
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a předškolní dítě $7 D002675
650    _2
$a nemoci trávicího systému $x epidemiologie $7 D004066
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hospitalizace $x statistika a číselné údaje $7 D006760
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a novorozenec $7 D007231
650    _2
$a infekce $x epidemiologie $7 D007239
650    _2
$a délka pobytu $x statistika a číselné údaje $7 D007902
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a methadon $x terapeutické užití $7 D008691
650    _2
$a opiátová substituční terapie $x statistika a číselné údaje $7 D058850
650    _2
$a poruchy spojené s užíváním opiátů $x farmakoterapie $x epidemiologie $7 D009293
650    _2
$a těhotenství $7 D011247
650    _2
$a komplikace těhotenství $x farmakoterapie $x epidemiologie $7 D011248
650    _2
$a zpožděný efekt prenatální expozice $x epidemiologie $7 D011297
650    _2
$a registrace $7 D012042
650    _2
$a kožní nemoci $x epidemiologie $7 D012871
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Nechanská, Blanka $u Department of Addictology, First Faculty of Medicine, Charles University, Czech Republic. Institute of Health Information and Statistics of the, Czech Republic.
700    1_
$a Handal, Marte $u Norwegian institute of Public Health, Oslo, Norway.
700    1_
$a Mahic, Milada $u Norwegian institute of Public Health, Oslo, Norway.
700    1_
$a Mravčík, Viktor $u Department of Addictology, First Faculty of Medicine, Charles University, Czech Republic. National Monitoring Centre for Drugs and Addiction, Prague, Czech Republic.
700    1_
$a Gabrhelík, Roman $u Department of Addictology, First Faculty of Medicine, Charles University, Czech Republic.
773    0_
$w MED00000153 $t Addiction (Abingdon, England) $x 1360-0443 $g Roč. 114, č. 7 (2019), s. 1225-1235
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30725515 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222154059 $b ABA008
999    __
$a ok $b bmc $g 1599926 $s 1116467
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 114 $c 7 $d 1225-1235 $e 20190312 $i 1360-0443 $m Addiction $n Addiction $x MED00000153
GRA    __
$a 16-28157A $p Ministry of Health of the Czech Republic $2 International
GRA    __
$a NV16-28157A $p MZ0
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...